Punctuated evolution of prostate cancer genomes.

The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet (2013) 11.29

Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science (2014) 5.63

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer. N Engl J Med (2015) 5.39

Integrative clinical genomics of advanced prostate cancer. Cell (2015) 5.29

Clonal evolution in breast cancer revealed by single nucleus genome sequencing. Nature (2014) 4.13

A Big Bang model of human colorectal tumor growth. Nat Genet (2015) 3.77

The Molecular Taxonomy of Primary Prostate Cancer. Cell (2015) 3.29

Organoid cultures derived from patients with advanced prostate cancer. Cell (2014) 3.12

Whole-genome characterization of chemoresistant ovarian cancer. Nature (2015) 3.06

Integrative annotation of variants from 1092 humans: application to cancer genomics. Science (2013) 2.98

Tumor clone dynamics in lethal prostate cancer. Sci Transl Med (2014) 2.93

RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia. Nat Genet (2014) 2.72

Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancy. Cancer Cell (2014) 2.60

Emerging patterns of somatic mutations in cancer. Nat Rev Genet (2013) 2.50

Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell (2015) 2.39

Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue. Nat Genet (2015) 2.29

Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. Cell Rep (2014) 2.27

TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer. Cancer Cell (2016) 2.26

The mutational landscape of prostate cancer. Eur Urol (2013) 2.14

Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nat Med (2016) 2.04

A hormone-DNA repair circuit governs the response to genotoxic insult. Cancer Discov (2013) 1.97

Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing. Cell (2014) 1.85

Unraveling the clonal hierarchy of somatic genomic aberrations. Genome Biol (2014) 1.84

Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes. Science (2014) 1.74

Targeted genomic rearrangements using CRISPR/Cas technology. Nat Commun (2014) 1.70

Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution. Cancer Discov (2014) 1.69

Hypermutation in human cancer genomes: footprints and mechanisms. Nat Rev Cancer (2014) 1.67

ARID1B is a specific vulnerability in ARID1A-mutant cancers. Nat Med (2014) 1.66

Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer. Nat Commun (2016) 1.65

Mutational signatures: the patterns of somatic mutations hidden in cancer genomes. Curr Opin Genet Dev (2013) 1.62

Chromothripsis and beyond: rapid genome evolution from complex chromosomal rearrangements. Genes Dev (2013) 1.61

Expanding the computational toolbox for mining cancer genomes. Nat Rev Genet (2014) 1.60

A survey of intragenic breakpoints in glioblastoma identifies a distinct subset associated with poor survival. Genes Dev (2013) 1.55

Novel fusion transcripts associate with progressive prostate cancer. Am J Pathol (2014) 1.51

Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer. Nat Commun (2015) 1.49

Spatial genomic heterogeneity within localized, multifocal prostate cancer. Nat Genet (2015) 1.47

Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors. Neoplasia (2015) 1.44

Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer. Nat Commun (2016) 1.44

Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine. Genome Biol (2014) 1.44

Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome. Cancer Res (2016) 1.39

Inferring the global structure of chromosomes from structural variations. BMC Genomics (2015) 1.37

Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma. Proc Natl Acad Sci U S A (2014) 1.36

FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer. Genome Biol (2014) 1.36

Cancer evolution: mathematical models and computational inference. Syst Biol (2014) 1.36

Identifying driver mutations in sequenced cancer genomes: computational approaches to enable precision medicine. Genome Med (2014) 1.31

Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett's esophagus. Cancer Prev Res (Phila) (2013) 1.31

The first five years of single-cell cancer genomics and beyond. Genome Res (2015) 1.27

Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer. Nat Commun (2014) 1.27

ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer. Proc Natl Acad Sci U S A (2013) 1.26

Identification of neutral tumor evolution across cancer types. Nat Genet (2016) 1.25

SPOP mutations in prostate cancer across demographically diverse patient cohorts. Neoplasia (2014) 1.23

C. elegans whole-genome sequencing reveals mutational signatures related to carcinogens and DNA repair deficiency. Genome Res (2014) 1.21

Evolutionary determinants of cancer. Cancer Discov (2015) 1.19

Coordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancer. Cancer Res (2015) 1.18

The emerging role of speckle-type POZ protein (SPOP) in cancer development. Drug Discov Today (2014) 1.16

Evidence for molecular differences in prostate cancer between African American and Caucasian men. Clin Cancer Res (2014) 1.15

Laying a solid foundation for Manhattan--'setting the functional basis for the post-GWAS era'. Trends Genet (2014) 1.10

Role of non-coding sequence variants in cancer. Nat Rev Genet (2016) 1.10

APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity. Cancer Discov (2015) 1.10

Efficient inversions and duplications of mammalian regulatory DNA elements and gene clusters by CRISPR/Cas9. J Mol Cell Biol (2015) 1.07

Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer. Genome Biol (2014) 1.04

An arranged marriage for precision medicine: hypoxia and genomic assays in localized prostate cancer radiotherapy. Br J Radiol (2014) 1.04

The tandem duplicator phenotype as a distinct genomic configuration in cancer. Proc Natl Acad Sci U S A (2016) 1.04

Targeting poly(ADP-ribose) polymerase and the c-Myb-regulated DNA damage response pathway in castration-resistant prostate cancer. Sci Signal (2014) 1.03

The Autophagy Machinery Controls Cell Death Switching between Apoptosis and Necroptosis. Dev Cell (2016) 1.02

Which, when and why? Rational use of tissue-based molecular testing in localized prostate cancer. Prostate Cancer Prostatic Dis (2015) 1.02

Chromoplexy: a new category of complex rearrangements in the cancer genome. Cancer Cell (2013) 1.01

Punctuated copy number evolution and clonal stasis in triple-negative breast cancer. Nat Genet (2016) 1.01

Molecular pathways and targets in prostate cancer. Oncotarget (2014) 1.00

Pediatric solid tumor genomics and developmental pliancy. Oncogene (2015) 1.00

Cancer systems biology: embracing complexity to develop better anticancer therapeutic strategies. Oncogene (2014) 1.00

Concordance of deregulated mechanisms unveiled in underpowered experiments: PTBP1 knockdown case study. BMC Med Genomics (2014) 0.98

Mediator kinase module and human tumorigenesis. Crit Rev Biochem Mol Biol (2015) 0.98

Sequential use of novel therapeutics in advanced prostate cancer following docetaxel chemotherapy. Ther Adv Urol (2014) 0.96

Centrosome dysfunction contributes to chromosome instability, chromoanagenesis, and genome reprograming in cancer. Front Oncol (2013) 0.96

Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment. Cancer Epidemiol Biomarkers Prev (2014) 0.95

A small molecule that binds and inhibits the ETV1 transcription factor oncoprotein. Mol Cancer Ther (2014) 0.94

Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer. Mol Cancer Res (2014) 0.94

Concepts in solid tumor evolution. Trends Genet (2015) 0.94

Targeting the adaptive molecular landscape of castration-resistant prostate cancer. EMBO Mol Med (2015) 0.93

SPOP mutation leads to genomic instability in prostate cancer. Elife (2015) 0.93

Sustained complete response to CTLA-4 blockade in a patient with metastatic, castration-resistant prostate cancer. Cancer Immunol Res (2014) 0.93

Poly (ADP-ribose) polymerase inhibitor: an evolving paradigm in the treatment of prostate cancer. Asian J Androl (2014) 0.92

HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular survey. Am J Surg Pathol (2014) 0.92

Comprehensive characterization of complex structural variations in cancer by directly comparing genome sequence reads. Nat Biotechnol (2014) 0.91

ShatterProof: operational detection and quantification of chromothripsis. BMC Bioinformatics (2014) 0.91

A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men. EBioMedicine (2015) 0.91

Evolving understanding of the CLL genome. Semin Hematol (2014) 0.91

Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution. Nat Commun (2015) 0.90

Prostate cancer ETS rearrangements switch a cell migration gene expression program from RAS/ERK to PI3K/AKT regulation. Mol Cancer (2014) 0.90

A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer. Oncotarget (2015) 0.90

Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking. Nat Genet (2016) 0.89

ERG induces taxane resistance in castration-resistant prostate cancer. Nat Commun (2014) 0.89

Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assay. Proc Natl Acad Sci U S A (2016) 0.88

Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls. ESMO Open (2016) 0.88

Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer. Oncotarget (2016) 0.88

The genomic landscape of prostate cancer. Int J Mol Sci (2013) 0.88

Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization. J Pathol (2015) 0.87

Genomic hallmarks of localized, non-indolent prostate cancer. Nature (2017) 0.87

Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells. Genome Res (2015) 0.87

Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics (2009) 190.94

Global cancer statistics. CA Cancer J Clin (2011) 185.92

A genetic model for colorectal tumorigenesis. Cell (1990) 44.37

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science (2005) 39.06

KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res (2011) 30.20

Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell (2011) 16.72

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol (2013) 16.13

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature (2005) 15.83

The genomic complexity of primary human prostate cancer. Nature (2011) 14.06

The mutational landscape of lethal castration-resistant prostate cancer. Nature (2012) 11.82

Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature (2007) 10.94

Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol (2012) 10.87

The life history of 21 breast cancers. Cell (2012) 10.59

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet (2012) 9.93

GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol (2011) 9.60

TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. Cancer Res (2006) 7.61

TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion. Am J Surg Pathol (2007) 6.09

Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell (2012) 6.07

Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev (2010) 5.83

Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell (2009) 5.74

SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature (2011) 4.57

Roles for Nkx3.1 in prostate development and cancer. Genes Dev (1999) 4.30

Chd1 regulates open chromatin and pluripotency of embryonic stem cells. Nature (2009) 4.13

Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers. Proc Natl Acad Sci U S A (2011) 3.54

Distinct genomic aberrations associated with ERG rearranged prostate cancer. Genes Chromosomes Cancer (2009) 3.03

TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation. Oncogene (2008) 2.94

DNA replication timing and long-range DNA interactions predict mutational landscapes of cancer genomes. Nat Biotechnol (2011) 2.62

Chromothripsis and cancer: causes and consequences of chromosome shattering. Nat Rev Cancer (2012) 2.17

Combined loss of PTEN and p27 expression is associated with tumor cell proliferation by Ki-67 and increased risk of recurrent disease in localized prostate cancer. Clin Cancer Res (2003) 1.96

Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res (1995) 1.85

Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability. Genome Res (2012) 1.82

Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer. Oncogene (2011) 1.50

Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness. Oncogene (2011) 1.33

Secondary structure formation and DNA instability at fragile site FRA16B. Nucleic Acids Res (2010) 1.11

The genomic landscape of prostate cancer. Front Endocrinol (Lausanne) (2012) 1.07

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46

Genome sequencing in microfabricated high-density picolitre reactors. Nature (2005) 150.21

The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res (2010) 97.51

Initial sequencing and comparative analysis of the mouse genome. Nature (2002) 96.15

A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39

Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature (2007) 75.09

MicroRNA expression profiles classify human cancers. Nature (2005) 69.12

Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature (2007) 65.18

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science (2004) 61.56

A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet (2011) 59.36

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet (2003) 53.59

Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science (2007) 51.70

The structure of haplotype blocks in the human genome. Science (2002) 50.88

A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell (2006) 48.80

Integrative genomics viewer. Nat Biotechnol (2011) 42.83

The generic genome browser: a building block for a model organism system database. Genome Res (2002) 42.64

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell (2010) 39.09

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science (2005) 39.06

Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature (2009) 35.48

Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet (2008) 35.06

Integrating common and rare genetic variation in diverse human populations. Nature (2010) 32.30

The landscape of somatic copy-number alteration across human cancers. Nature (2010) 31.88

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature (2012) 31.78

Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals. Nature (2005) 31.60

Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature (2008) 30.29

Somatic mutations affect key pathways in lung adenocarcinoma. Nature (2008) 30.02

Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science (2009) 29.83

Sequencing and comparison of yeast species to identify genes and regulatory elements. Nature (2003) 29.16

Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21

Transcriptional regulatory code of a eukaryotic genome. Nature (2004) 27.21

Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol (2009) 27.17

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. N Engl J Med (2005) 26.35

The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science (2006) 25.99

Efficiency and power in genetic association studies. Nat Genet (2005) 25.56

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08

Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature (2005) 23.04

High-quality draft assemblies of mammalian genomes from massively parallel sequence data. Proc Natl Acad Sci U S A (2010) 22.97

ARACHNE: a whole-genome shotgun assembler. Genome Res (2002) 22.72

Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet (2008) 22.35

Detecting recent positive selection in the human genome from haplotype structure. Nature (2002) 22.00

Signatures of mutational processes in human cancer. Nature (2013) 21.63

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer Res (2004) 21.36

A molecular signature of metastasis in primary solid tumors. Nat Genet (2002) 21.36

Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet (2008) 20.73

Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A (2009) 20.66

Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet (2008) 20.66

ALLPATHS: de novo assembly of whole-genome shotgun microreads. Genome Res (2008) 20.61

International network of cancer genome projects. Nature (2010) 20.35

Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature (2013) 20.16

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med (2013) 19.87

Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat Genet (2008) 19.55

Genomic maps and comparative analysis of histone modifications in human and mouse. Cell (2005) 18.96